Mark A. Wilson Steps Down as Chief Legal Officer of Nektar Therapeutics

Mark A. Wilson left the role of Chief Legal Officer at Nektar Therapeutics on November 21, 2025, according to an SEC filing.

NameMark A. Wilson
RoleChief Legal Officer
CompanyNektar Therapeutics
IndustryBiotechnology
LocationSan Francisco, CA
MoveDeparture
DateNovember 21, 2025
Sourcean SEC filing

Nektar Therapeutics announced on November 21, 2025 that Mark A. Wilson will step down as Chief Legal Officer effective December 31, 2025. (Source: an SEC filing.)

Other general counsel moves in November 2025

Browse every appointment in the General Counsel Directory.

Source: an SEC filing. InhouseBlog summarizes publicly reported general counsel moves and links to the original report.

Does this information need updating? Email us at info@inhouseblog.com.